Literature DB >> 6802291

Captopril in essential hypertension; contrasting effects of adding hydrochlorothiazide or propranolol.

G A MacGregor, N D Markandu, R A Banks, J Bayliss, J E Roulston, J C Jones.   

Abstract

Twenty-four patients with moderate to severe hypertension were treated for four weeks with captopril, an oral inhibitor of angiotensin-converting enzyme. The fall in blood pressure with captopril alone correlated with pretreatment plasma renin activity. The effect of adding either hydrochlorothiazide or propranolol to the captopril treatment was then studied. The addition of hydrochlorothiazide to captopril produced a dose-dependent fall in blood pressure. At the higher dose of the diuretic this fall in blood pressure correlated with weight loss, suggesting that when the diuretic-induced compensatory rise in angiotensin II is prevented by captopril the fall in blood pressure becomes dependent on loss of sodium and water. In contrast, the addition of propranolol to captopril produced no further fall in blood pressure, suggesting that inhibition of angiotensin-converting enzyme prevents the blood pressure lowering effect of propranolol. This may have implications for the mechanism whereby beta-blockers alone lower blood pressure. These contrasting effects of hydrochlorothiazide and propranolol in the presence of captopril indicate that in patients whose hypertension is not controlled by captopril alone the addition of increasing doses of diuretic is likely to control the blood pressure. The addition of a beta-blocker, however, is less likely to be effective.

Entities:  

Mesh:

Substances:

Year:  1982        PMID: 6802291      PMCID: PMC1496699          DOI: 10.1136/bmj.284.6317.693

Source DB:  PubMed          Journal:  Br Med J (Clin Res Ed)        ISSN: 0267-0623


  15 in total

1.  Clinical experience with blockade of the renin-angiotensin-aldosterone system by an oral converting-enzyme inhibitor (SQ 14,225, captopril) in hypertensive patients.

Authors:  D B Case; S A Atlas; J H Laragh; J E Sealey; P A Sullivan; D N McKinstry
Journal:  Prog Cardiovasc Dis       Date:  1978 Nov-Dec       Impact factor: 8.194

2.  Unexpected pressor responses to propranolol in essential hypertension. An interaction between renin, aldosterone and sympathetic activity.

Authors:  J I Drayer; H J Keim; M A Weber; D B Case; J H Laragh
Journal:  Am J Med       Date:  1976-05-31       Impact factor: 4.965

3.  Antihypertensive effect of the oral angiotensin converting-enzyme inhibitor SQ 14225 in man.

Authors:  H Gavras; H R Brunner; G A Turini; G R Kershaw; C P Tifft; S Cuttelod; I Gavras; R A Vukovich; D N McKinstry
Journal:  N Engl J Med       Date:  1978-05-04       Impact factor: 91.245

Review 4.  Captopril in the treatment of clinical hypertension and cardiac failure.

Authors:  A B Atkinson; J I Robertson
Journal:  Lancet       Date:  1979-10-20       Impact factor: 79.321

5.  Measurement of plasma renin activity by radioimmunoassay after prolonged cold storage.

Authors:  J E Roulston; G A MacGregor
Journal:  Clin Chim Acta       Date:  1978-08-15       Impact factor: 3.786

6.  Long-term effects of captopril (SQ14 225) on blood-pressure and hormone levels in essential hypertension.

Authors:  C I Johnston; J A Millar; B P McGrath; P G Matthews
Journal:  Lancet       Date:  1979-09-08       Impact factor: 79.321

7.  Renin--angiotensin system in mild essential hypertension. The functional significance of angiotensin II in untreated and thiazide-treated hypertensive patients.

Authors:  H Ibsen; A Leth; H Hollnagel; A M Kappelgaard; M D Nielsen; J Giese
Journal:  Clin Sci Mol Med Suppl       Date:  1978-12

8.  Relationship between the hypotensive and renin-stimulating actions of diuretic therapy in hypertensive patients.

Authors:  G Leonetti; L Terzoli; C Sala; C Bianchini; L Sernesi; A Zanchetti
Journal:  Clin Sci Mol Med Suppl       Date:  1978-12

9.  Essential hypertension: effect of an oral inhibitor of angiotensin-converting enzyme.

Authors:  G A MacGregor; N D Markandu; J E Roulston; J C Jones
Journal:  Br Med J       Date:  1979-11-03

10.  Innappropriate renin secretion unmasked by captopril (SQ 14 225) in hypertension of chronic renal failure.

Authors:  H R Brunner; B Waeber; J P Wauters; G Turin; D McKinstry; H Gavras
Journal:  Lancet       Date:  1978-09-30       Impact factor: 79.321

View more
  13 in total

Review 1.  Preclinical studies on angiotensin converting enzyme inhibitors.

Authors:  I L Natoff
Journal:  Cardiovasc Drugs Ther       Date:  1987       Impact factor: 3.727

Review 2.  Captopril. An update of its pharmacodynamic and pharmacokinetic properties, and therapeutic use in hypertension and congestive heart failure.

Authors:  R N Brogden; P A Todd; E M Sorkin
Journal:  Drugs       Date:  1988-11       Impact factor: 9.546

Review 3.  Angiotensin converting enzyme inhibitors and moderate hypertension.

Authors:  D McAreavey; J I Robertson
Journal:  Drugs       Date:  1990-09       Impact factor: 9.546

4.  Lack of effect of beta-blocker on flat dose response to thiazide in hypertension: efficacy of low dose thiazide combined with beta-blocker.

Authors:  G A MacGregor; R A Banks; N D Markandu; J Bayliss; J Roulston
Journal:  Br Med J (Clin Res Ed)       Date:  1983-05-14

Review 5.  Inhibitors of the angiotensin I converting enzyme as antihypertensive drugs.

Authors:  P A Van Zwieten; A De Jonge; P B Timmermans
Journal:  Pharm Weekbl Sci       Date:  1983-10-21

6.  Plasma renin activity does not predict the antihypertensive efficacy of chlorthalidone.

Authors:  A Salvetti; R Pedrinelli; G Bartolomei; M A Cagianelli; G Cinotti; P Innocenti; C Loni; G Saba; P Saba; L Papi
Journal:  Eur J Clin Pharmacol       Date:  1987       Impact factor: 2.953

7.  Pharmacokinetics and biological effects of captopril and hydrochlorothiazide after acute and chronic administration either alone or in combination in hypertensive patients.

Authors:  J F Giudicelli; C Richer; A Mattei
Journal:  Br J Clin Pharmacol       Date:  1987       Impact factor: 4.335

8.  [Results of a 5-year study with captopril in patients with severe therapy-resistant hypertension].

Authors:  J Schrader; G Schoel; F Scheler
Journal:  Klin Wochenschr       Date:  1986-08-01

9.  The influence of cardiovascular and antiinflammatory drugs on thiazide-induced hemodynamic and saluretic effects.

Authors:  H Knauf; M A Bailey; G Hasenfuss; E Mutschler
Journal:  Eur J Clin Pharmacol       Date:  2006-09-09       Impact factor: 2.953

Review 10.  Angiotensin converting enzyme inhibitors in the treatment of hypertension: efficacy, metabolic effects and side effects.

Authors:  M H Weinberger
Journal:  Cardiovasc Drugs Ther       Date:  1987       Impact factor: 3.727

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.